Mahmoud, A., Alsawy, S., Albadry, A. (2017). Correlation between Nicotinamide Phosphoribosyl Transferase(NAMPT) level andclinicopathological criteria in colorectal cancer patients. test, 21(2), 167-176. doi: 10.21608/smj.2017.41291
Alia Mahmoud; Samer Alsawy; Ashraf Albadry. "Correlation between Nicotinamide Phosphoribosyl Transferase(NAMPT) level andclinicopathological criteria in colorectal cancer patients". test, 21, 2, 2017, 167-176. doi: 10.21608/smj.2017.41291
Mahmoud, A., Alsawy, S., Albadry, A. (2017). 'Correlation between Nicotinamide Phosphoribosyl Transferase(NAMPT) level andclinicopathological criteria in colorectal cancer patients', test, 21(2), pp. 167-176. doi: 10.21608/smj.2017.41291
Mahmoud, A., Alsawy, S., Albadry, A. Correlation between Nicotinamide Phosphoribosyl Transferase(NAMPT) level andclinicopathological criteria in colorectal cancer patients. test, 2017; 21(2): 167-176. doi: 10.21608/smj.2017.41291

Correlation between Nicotinamide Phosphoribosyl Transferase(NAMPT) level andclinicopathological criteria in colorectal cancer patients

Sohag Medical Journal
Article 19, Volume 21, Issue 2, July 2017, Pages 167-176    PDF (105.85 K)
Document Type: Original Article
DOI: 10.21608/smj.2017.41291
Authors
Alia Mahmoud1; Samer Alsawy1; Ashraf Albadry2
1Departments of Biochemistry,Sohag university
2General Surgery,Faculty of Medicine ,Sohag university
Abstract
Background:Colorectal cancer (CRC) is one of the most common cancers worldwide, with the highest incidence rates in western countriesThe 5-year survival rate for a patient diagnosed with stage I or II colorectal cancer, is up to 90%. However, the 5-year survival rate for patients diagnosed with stage IV disease, once the cancer has metastasized to other organs, is only 12%.
Aim of the work :is todetect levels of Visfatin,Nitric oxide,Lipid peroxide and Superoxide dismutase in  serum of patients with colorectal cancer and compare results with patients with benign colorectal tumor and with control group and detect the relation of each of them to the clinic-pathological criteria in colorectal cancer.
 Patients and methods:This study was performed at Sohag University Hospital from December 2015 to June 2016, eighty-five persons were enrolled in the study and divided into three groups. 60 patients with colorectal cancer, 10 patients with begin colorectal tumors all of them were selected from SohagCancer Institute and Sohag University Hospital and 15 healthy persons of matched age and sex without evidence of any cancer (controls). All were matched for age and sex, for each participantcomplete medical history, physical examination, and routine investigations were done.Nicotinamidephosphoribosyltransferase (NAMPT) was measured by Eliza kitsNitric oxide and Superoxide dismutase (SOD) activities level were  measured by colorimetry..
Results:The  serum levels of visfatin"NAMPT",NO and lipid peroxidation products as "MDA"in  patients  with benign tumor were  significantly higher than in healthy controls ,in patients with colorectal cancer the levels is significantly higher than in healthy controls and patients with benign tumor (p-value < 0.001), and there is significant relations between levels of NAMPT and the clinicopathologicalcritiria of the cancer ,In contrast the levels of antioxidant enzyme (superoxide dismutase) where altered"decreased "in colorectal  cancer group , benign lesions group comparing to healthy control group .
Conculsion:our study relieved that there is positive relation between level of visfatin and colorectal caneroccurance and cancer clinicopathological criteria . Also our study relievedColorectal carcinogenesis is associated with serious oxidative stress and confirms that gradual advancement of oxidative-antioxidative disorders is followed by progression of colorectal cancer.
Keywords
NAMPT; Oxidants; Antioxidant activity; Colorectal cancer . E-mail:aliakhairy88@gmail.com.Tel:01023742566
Supplementary Files
References
  1. Siegel R, Ma J, Zou Z, Jemal A(2014): Cancer statistics, CA Cancer J Clin.64:9–29.
  2. Bosman FT, Hamilton SR, Lambert R (2014): Colorectal cancer. In: Stewart BW, Wild CP. World Cancer Report 2014, International Agency for Research on Cancer; pp. 558–75.
  3. Edwards BK et al(2006):Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates. Cancer (2009) 116(3):544-573.
  4. Koyanagi K, Bilchik AJ, Saha S, Turner RR, Wiese D, McCarter M. et al (2008):Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res.; 14:7391–6.
  5. Samal B, Sun Y, Stearns G, Xie C, Suggs S and McNiece I (1994): Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol Feb;14(2):1431-7.
  6. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, et al; (2005):"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin". Science. 307 (5708)426–30.
  7. Imai. S.I (2009): “Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases,” Current Pharmaceutical Design, vol. 15, no. 1, pp. 20–28.
  8. Galli M, Van Gool F, Rongvaux A, Andris F and Leo O (2009): The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer.Cancer Res. 2010 Jan 1;70(1):8-11. Epub 2009 Dec 22.
  9. Zhang LQ, Heruth DP and Ye SQ(2011): Nicotinamide Phosphoribosyltransferase in Human Diseases Bioanal Biomed Jan 7; 3:13-25.
  10. Hufton SE, Moerkerk PT, Brandwijk R, de Bruine AP, Arends JW, Hoogenboom HR (1999): A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization.FEBSLettDec 10;463(1-2):77-82.
  11. Chen M, Wang Y, Li Y, Zhao L, Ye S, Wang S(2013) : Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients. Asia-Pacific journal of clinical oncology .
  12. Valko.M, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser (2007): “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84.
  13. Cejas. P, E. Casado, C. Belda-Iniesta et al (2004) :“Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain),” Cancer Causes and Control, vol. 15, no. 7, pp. 707–719.
  14. Mena. S, A. Ortega, and J. M. Estrela (2009): “Oxidative stress in environmental-induced carcinogenesis,” Mutation Research, vol. 674, no. 1-2, pp. 36–44.
  15. UpadhyaSharmila, SubramanyaUpadhya, S. Krishna Mohan, K. Vanajakshamma,MamathaKunder, Seema Mathias(2004): OXIDANT-ANTIOXIDANT STATUS IN COLORECTAL CANCER PATIENTSBEFORE AND AFTER TREATMENT indian Journal of Clinical Biochemistry, , 19 (2) 80-83.
  16. Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, Kato K, Hamaguchi T, Shimada Y (2010):Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.Cancer Sci.;101(5):1286-91. Epub 2010 Jan 31.
  17. XiaoqunLv,Lingyun Zhang,Yanyan Zhu,Harun M. Said,Jimin Shi, and Guoxiong Xu(2015): Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer; 6(9): 849–858.
  18. El-Deek.S.EM ,Naglaa K Idriss ,Randas Hana , Madleen AA Abdou , Doaa W Maksemose , Madeha M zakhary (2013):The Role of Angiogenic Biomarkers in Gastrointestinal CancerIbnosina J Med BS 2013,5(4):196-205
  19. Haklar. G, Sayin-Özveri. E, Yüksel .M, Ö. Aktan. A, and YalçinA. S (2001): “Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors,” Cancer Letters, vol. 165, no. 2, pp. 219–224.
Statistics
Article View: 167
PDF Download: 227